Related Experiment Video
Updated: Mar 20, 2026
Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors
Published on: March 1, 2020
Cancer stem cell targets - a review
1Department of Oncology, Weifang Yidu Central Hospital, Qingzhou, Weifang, Shandong, China. 1335885299@qq.com.
Abstract:
The varied therapeutic approaches like radiotherapy, chemotherapy, surgery, etc. primarily aimed to target cancer cells specifically. Despite these efforts, they are not completely successful in eliminating this deadly pathological state. These failures ultimately lead to cancer reoccurrence, which is again, another burning problem associated with cancer. The prime reason for the above observation has been found to be the development of resistance by cancer cells towards cancer drugs or cancer-initiating cells (cancer stem cells) remain unaffected by existing treatment procedures. Recent research has evolved two drugs, salinomycin and apoptin, that hold great potential for the future of cancer treatment not only for restricting malignancy, but also in preventing tumor recurrence. The present review article will put light on these new upcoming cancer stem cell targeting agents.
Insights
New cancer stem cell targeting agents, salinomycin and apoptin, show promise in overcoming drug resistance and preventing cancer recurrence, offering hope for more effective cancer treatments.
Area of Science:
- Oncology
- Cancer Research
- Pharmacology
Background:
- Current cancer therapies like chemotherapy and radiotherapy often fail due to cancer cell resistance and the persistence of cancer stem cells.
- This resistance leads to incomplete tumor eradication and a high rate of cancer recurrence, a significant challenge in oncology.
Purpose of the Study:
- To review novel therapeutic agents, salinomycin and apoptin, that specifically target cancer stem cells.
- To highlight their potential in overcoming treatment resistance and preventing tumor recurrence.
Main Methods:
- Review of recent scientific literature on salinomycin and apoptin.
- Analysis of their mechanisms of action against cancer stem cells.
Main Results:
- Salinomycin and apoptin demonstrate significant potential in targeting cancer stem cells.
- These agents may offer a new strategy to combat drug resistance and prevent cancer relapse.
Conclusions:
- Salinomycin and apoptin represent promising advancements in cancer therapy.
- Targeting cancer stem cells with these agents could lead to improved patient outcomes and reduced recurrence rates.
Related Concept Videos
02:40Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:40Cancer Stem Cells and Tumor Maintenance
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:57Targeted Cancer Therapies
01:18Distinctive Features of Adult Stem Cells vs Cancer Stem Cells
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
01:21Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...